(Natural News)—What developed nation’s government would want their own people sick and dying? What country would suppress health information that would save millions of people from suffering, including the same people who stand up for the country, fight for freedom and independence, and support the Republic? You guessed it. The beloved U.S. of A.
Newly released documents obtained through a Freedom of Information Act (FOIA) request reveal that senior U.S. health officials mischaracterized early studies on COVID-19 immunity, downplayed evidence supporting natural immunity, and deliberately chose not to update public messaging because they feared it would be “too costly.”
- Misrepresentation of Studies: In August 2021, the CDC claimed vaccines offered better protection than prior infection, citing a Kentucky study. However, the study only evaluated vaccination benefits among previously infected individuals — not against natural immunity alone. Officials, including Francis Collins and Anthony Fauci, promoted this misleading conclusion publicly.
- Suppression of Contradictory Evidence: Shortly after, U.S. officials privately acknowledged an Israeli study showing that natural immunity from prior infection provided stronger and longer-lasting protection than vaccination. Despite recognizing its quality and findings, senior officials decided not to update public guidance.
- Internal Acknowledgment vs. Public Messaging: Emails revealed officials, including Collins, Fauci, and Surgeon General Vivek Murthy, discussed the Israeli study’s implications. CDC’s John Brooks even praised the study, noting infection-induced immunity could outlast vaccine protection. Still, officials maintained the narrative that vaccines were superior, fearing it was “too costly” to admit otherwise.
- Erosion of Public Trust: Watchdog group Protect the Public’s Trust accused health officials of scientific integrity violations, arguing they knowingly misled the public by burying data favorable to natural immunity. Critics say this deliberate suppression damaged public confidence in health institutions — damage that may take decades to repair.
Health officials downplayed data on natural immunity, misrepresented study, never updated findings
In August 2021, the Centers for Disease Control and Prevention (CDC) declared that vaccines offered greater protection against COVID-19 than prior infection. The agency based this claim on a Kentucky study but misrepresented its scope. The study had not concluded that vaccination was universally superior to natural immunity. Instead, it found that for people who had already been infected, vaccination could provide additional protection against reinfection. Nonetheless, the CDC’s press release framed the findings as evidence that vaccines were broadly more protective, a claim amplified by National Institutes of Health (NIH) Director Francis Collins in a televised interview.
Watchdog group Protect the Public’s Trust argues that the CDC and Collins misled the public by misrepresenting the Kentucky study and ignoring its limitations. Shortly afterward, internal communications show that officials, including Collins, Anthony Fauci, and Surgeon General Vivek Murthy, were made aware of an Israeli study with a starkly different conclusion. That study suggested that natural immunity provided stronger and longer-lasting protection against reinfection than two doses of mRNA vaccines. Internal emails show Fauci and Collins recognized the study’s robustness, with CDC scientist John Brooks praising its design and analysis. Brooks even admitted that infection-induced immunity might last longer than vaccine-induced immunity, particularly within the first six months.
Despite acknowledging these findings privately, officials concluded it would be “too costly” to change course and risk undermining the push for widespread vaccination. Instead, public messaging remained consistent: Vaccines were said to provide better protection than natural infection. Internal communications reveal that health officials believed acknowledging the Israeli study could discourage vaccination, even if the evidence supported natural immunity as stronger in some cases.
Protect the Public’s Trust previously filed a scientific integrity complaint in October 2021, accusing the agencies of misrepresenting research and suppressing contradictory data. The group’s director, Michael Chamberlain, argued that officials advanced a political narrative at the expense of public trust, noting that “they admitted among themselves that infection-induced immunity may have provided better protection, but decided that leveling with the public came at ‘too great a cost.’”
Ultimately, no meaningful updates were made to official messaging. In October 2021, the CDC doubled down, publishing a science brief that dismissed observational studies like Israel’s and claimed the evidence for natural immunity was limited compared to vaccine data — even as its own scientists privately validated the study’s credibility.
The revelations raise serious concerns about transparency and scientific integrity during the pandemic. By misrepresenting findings and withholding evidence, health officials may have undermined public trust in institutions at a critical moment. Critics argue the long-term damage to credibility could take decades to repair.
Bookmark Infections.news to get uncensored health information that Big Pharma, Big Media, and Big Tech do NOT want you to find out about.
Sources for this article include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.